Although we could notice a trend of decrease in PON1 concentration in HCC compared to benign liver diseases, the differences between HCC and FNH or Cyst patients failed to reach statistical significance (both P>0.05), but the PON1 concentration was significantly higher in hemangioma patients than in HCC (P<0.05).
← all excerpts
Serum PON1 as a biomarker for the estimation of microvascular invasion in hepatocellular carcinoma.
1
0.0500
0.0500